Want to join the conversation?
During 3Q15, $ROP's gross margins were up 130BPs to 60.7% over last year and even up sequentially from the second quarter. EBITDA margins were up 80BPs to 34.4%. Free cash flow was $220MM, which was up sharply from the second quarter of $162MM & $220MM of free cash flow represents 137% conversion.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?